BMPR2 and pulmonary arterial hypertension: Serotonin (5-HT), a key mediator of PAH, has been associated with the PAH phenotype of BMPR2 deficient mice by inhibiting BMP signaling, enhanced pulmonary arteries contractile and promoted the PASMCs proliferation (Long et al., 2006; Hood et al., 2017).